mitoxantrone has been researched along with Metabolism, Inborn Errors in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On mitoxantrone treatment there was a considerable neurologic recovery." | 1.34 | 3-methylcrotonyl-CoA carboxylase deficiency and severe multiple sclerosis. ( Andersen, O; Darin, N; Holme, E; Holmgren, D; Wiklund, LM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darin, N | 1 |
| Andersen, O | 1 |
| Wiklund, LM | 1 |
| Holmgren, D | 1 |
| Holme, E | 1 |
1 other study available for mitoxantrone and Metabolism, Inborn Errors
| Article | Year |
|---|---|
3-methylcrotonyl-CoA carboxylase deficiency and severe multiple sclerosis.
Topics: Adjuvants, Immunologic; Adolescent; Analgesics; Brain; Carbon-Carbon Ligases; Female; Humans; Interf | 2007 |